Dasatinib monohydrate NEW

Dasatinib Monohydrate: Product Overview

Definition
Dasatinib Monohydrate is a pharmaceutical compound used as an oral medication in cancer treatment. It is the monohydrate form of Dasatinib, a potent tyrosine kinase inhibitor primarily used to treat chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).

Function
Dasatinib Monohydrate works by inhibiting specific tyrosine kinases, including BCR-ABL and Src family kinases, which play a crucial role in the growth of cancer cells. By blocking these kinases, Dasatinib Monohydrate helps prevent the spread and growth of abnormal cancer cells.

Applications

· Chronic Myelogenous Leukemia (CML): Primarily used to treat CML by targeting and inhibiting the BCR-ABL fusion protein.

· Acute Lymphoblastic Leukemia (ALL): Used in the treatment of ALL, particularly in Philadelphia chromosome-positive cases.

· Other cancers: Under investigation for potential applications in various other cancer treatments due to its broad kinase inhibition profile.